09/03/2026
“We are not building Datascan so we can package it up and sell it to the highest bidder. We are building it to last.” — Kevin Minassian, President and Owner, Datascan
Datascan announced on August 6 that it intends to remain independently owned and dedicated exclusively to independent community pharmacies.
The company framed the decision against a decade of consolidation in pharmacy software, during which competing platforms have been acquired, merged, discontinued or folded into larger corporate structures.
Datascan’s announcement is a competitive position as much as a philosophy. The company is selling independence to independents, and that is a coherent pitch in a consolidating market. It is also, for once, a pitch that can be tested against behavior over time.
What This Means for Independent Pharmacies
Take the announcement for what it is: one vendor stating a position. It is not an industry trend, and it does not change anyone’s contract. What it does is make the question legitimate to ask out loud.
If you are evaluating a pharmacy software vendor — or renewing with the one you have — ownership structure now belongs on the same page as features and price. So does the processor question, which is the one most likely to be quietly costing you money right now.
Want to know more, including what went into this decision and some FAQ's? Read the entire article by clicking the link below.
Datascan publicly commits to staying independently owned and rules out a private-equity sale. What the pledge means for pharmacy owners weighing vendor risk, processor mandates and support.
